In contrast, only 13 out of all 233 or 5.6% of the CD44+ CRC showed similar dim CD44 intensities when compared with the erythroblasts and additionally, supports the conclusion of a distinct cell phenotype. The gene discussed is CD44; the disease is colorectal carcinoma.